Leveraging Generative AI to Prioritize Drug Repurposing Candidates: Validating Identified Candidates for Alzheimer's Disease in Real-World Clinical Datasets is a research paper published in Research Square (2023). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1R01AG069900-01
Drug repositioning for Alzheimer's disease via genetics, electronic health records, and human iPSC models
National Institutes of Health
Grant: 1F30AG080885-01
Computational drug repurposing for Alzheimer's disease
National Institutes of Health
Grant: 5R01GM139891-02
PheMAP: Measured, Automated Profile to Facilitate High Throughput Phenotyping
National Institutes of Health
Grant: 5R35GM131770-03
Pharmacogenetics to improve drug therapy
NIA NIH HHS
Grant: R01 AG069900
NIGMS NIH HHS
Grant: R01 GM139891
NIA NIH HHS
Grant: F30 AG080885
NIGMS NIH HHS
Grant: P50 GM115305
NIGMS NIH HHS
Grant: R35 GM131770
Fields of Study
Keywords
Sustainable Development Goals